metformin has been researched along with Dyskinesia Syndromes in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Lactic acidosis was present in 2 patients at presentation and serum lactate was elevated in 7/15 patients tested." | 1.72 | The extrapyramidal syndromes of chronic kidney disease and dialysis (EPS-CKDD): diagnostic criteria, risk factors and prognosis. ( Agarwal, A; Chemmanam, T; Irish, AB; Manickavasagar, R; Prentice, DA; Youssef, A, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Manickavasagar, R | 1 |
| Chemmanam, T | 1 |
| Youssef, A | 1 |
| Agarwal, A | 1 |
| Prentice, DA | 1 |
| Irish, AB | 1 |
1 other study available for metformin and Dyskinesia Syndromes
| Article | Year |
|---|---|
The extrapyramidal syndromes of chronic kidney disease and dialysis (EPS-CKDD): diagnostic criteria, risk factors and prognosis.
Topics: Acidosis, Lactic; Basal Ganglia Diseases; Child, Preschool; Diabetes Mellitus, Type 2; Female; Human | 2022 |